Pronota N.V.

http://www.pronota.com

Pronota was founded in late 2004 to develop protein biomarker diagnostics derived from its proprietary platform that uniquely mines for low-abundance protein biomarkers in blood and other tissues. In this short time, it has successfully implemented its technology and made substantial progress in creating a diagnostic product development pipeline. Its MASStermind® protein biomarker discovery platform has demonstrated, across many projects, its unerring ability to discover clinically relevant and novel protein biomarkers. Its MASSterclass™ verification platform provides it with a way of verifying within a matter of weeks the prolific output from MASStermind without having to resort to the use of antibody based assays. *

	Start	2006-11-22 renamed
	Predecessor	Peakadilly N.V.
	Industry	diagnostic marker
	Industry 2	proteomic marker (diagnostics)
	Person	McCooke, Nick (Peakadilly/Pronota 200604–201201 CEO LEFT 1/12 before Solexa 1st CEO)

	Region	Zwijnaarde
	Country	Belgium
	Street	4 Technologiepark
	City	9052 Zwijnaarde
	Tel	+32-9-241-1164
	Fax	+32-9-241-1169
		Address record changed: 2012-01-17

Basic data	Employees	n. a.

		* Document for »About Section«: Pronota N.V.. (2/22/11). "Press Release: Pronota and Molecuence Announce Collaboration in Protein Biomarker Discovery". Ghent.

		Record changed: 2012-02-06

Follow Us!

Top News

Upcoming Events

Associations

Partners

Pronota N.V.

More documents for Pronota N.V.